MKS Instruments — The Essentials

Mid-cap Technology company MKS Instruments has moved -2.7% so far today on a volume of 624,651, compared to its average of 762,395. In contrast, the S&P 500 index moved -2.2%.

MKS Instruments trades -34.16% away from its average analyst target price of $126.11 per share. The 9 analysts following the stock have set target prices ranging from $90 to $170, and on average have given MKS Instruments a rating of buy.

Anyone interested in buying MKSI should be aware of the facts below:

  • MKS Instruments's current price is -2.9% away from its Graham number of $85.52 (a purchase price with a built-in margin of safety)

  • Based on its trailing earning per share of 7.28, MKS Instruments has a trailing 12 month Price to Earnings (P/E) ratio of 11.4 while the S&P 500 average is 15.97

  • MKSI has a forward P/E ratio of 7.0 based on its forward 12 month price to earnings (Eps) of $11.87 per share

  • The company has a price to earnings growth (PEG) ratio of -0.79 — a number near or below 1 signifying that MKS Instruments is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 1.9 compared to its sector average of 5.57

  • MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide.

  • Based in Andover, the company has 6,000 full time employees and a market cap of $4,604,752,384. MKS Instruments currently returns an annual dividend yield of 0.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.